Resources Contact Us Home
Oral general anesthetics and metabolitically resistant anticonvulsants

Image Number 7 for United States Patent #7026358.

The present invention is directed to novel themisone derivative compounds that have been modified to prevent the formation of the toxic metabolite, 2-phenyl-acrylamide. Compositions comprising such derivative compounds have activity as anesthetics and as neuroprotective agents.

  Recently Added Patents
Repeating frame battery with joining of cell tabs via welded-on male and female slip-fit connectors
Secure soft SIM credential transfer
Precision geolocation of moving or fixed transmitters using multiple observers
Semiconductor device including a clock generating circuit for generating an internal signal having a coarse delay line, a fine delay line and a selector circuit
Regenerative braking control to mitigate powertrain oscillation
Compositions substantially free of sodium chloride and methods for the storage of red blood cells
Nanofibers containing latent reactive groups
  Randomly Featured Patents
Feed forward amplifier with digital intermodulation control
Communications protocol processing by real time processor off-loading operations to queue for processing by non-real time processor
Cymbal holder with barb means retention of cushion pad
Mailbox assembly and associated methods
Process for the manufacture of a fiber reinforced composite material having a ceramic matrix and preheated carbon fibers
Double swing power unit
Low-profile surface mount filter
Substituted mono- and bipyridylmethylpyridones
Contact laser delivery system
Laser optics and diode laser